Compare CENTA & PAHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CENTA | PAHC |
|---|---|---|
| Founded | 1955 | 1946 |
| Country | | |
| Employees | N/A | N/A |
| Industry | Consumer Specialties | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.7B |
| IPO Year | N/A | N/A |
| Metric | CENTA | PAHC |
|---|---|---|
| Price | $34.23 | $52.78 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 4 | 3 |
| Target Price | ★ $35.75 | $34.33 |
| AVG Volume (30 Days) | 295.1K | ★ 299.1K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 0.92% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $1.82 | $15.34 |
| Revenue Next Year | $2.04 | $3.28 |
| P/E Ratio | ★ $13.44 | $23.13 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $25.97 | $16.16 |
| 52 Week High | $37.35 | $56.30 |
| Indicator | CENTA | PAHC |
|---|---|---|
| Relative Strength Index (RSI) | 74.15 | 73.32 |
| Support Level | $33.00 | $50.94 |
| Resistance Level | $34.51 | $52.89 |
| Average True Range (ATR) | 1.35 | 2.35 |
| MACD | 0.28 | 0.92 |
| Stochastic Oscillator | 86.37 | 80.17 |
Central Garden & Pet Co offers solutions that support healthier pets, greener lawns, and thriving gardens. Its products include dog and cat treats, chews, toys, beds, containment, grooming supplies, aquatics, small animal and bird supplies, equine and livestock products, insect control solutions, grass seed, wild bird feed, fertilizers, pest controls, live plants, and packet seeds, sold under brands such as Aqueon, Nylabone, Kaytee, Farnam, Pennington, Ferry Morse, Amdro, and Sevin. The company operates through two segments, Pet and Garden, and sells through retailers, independent stores, eCommerce channels, and professional markets. It has sales and distribution operations mainly across the United States, with additional facilities in Canada and Mexico.
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.